@quretech.com
QureTech Bio are addressing a significant unmet medical need by developing a new class of antibacterial agents that target antimicrobial resistance.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
PNG
About
Description
QureTech Bio AB is a pioneering brand dedicated to developing first-line drugs that tackle infectious diseases and combat antibiotic resistance. Founded on groundbreaking research conducted by esteemed groups at Umeå University in Sweden and Washington University in St. Louis, USA, QureTech Bio has attracted a team of experts who have joined as board members, researchers, and scientific advisors.
The company has secured soft funding from influential entities such as Umeå Biotech Incubator, the European Union Horizon 2020 program SME Instrument Phase 1, Swelife (a strategic innovation program funded by the Swedish innovation agency Vinnova), and the ENABLE-2 program via Vinnova. QureTech Bio's dedicated board of directors includes highly accomplished individuals such as Professor Sven Bergström, a leader in Microbiology at Umeå University, and Professor Christina Stallings, a Molecular Microbiology expert at Washington University. With a focus on innovation, QureTech Bio is well-positioned to revolutionize the pharmaceutical industry in its fight against infectious diseases
Company Type
Public Company
Company Size
2-10
Year Founded
2014
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online